IP Library Assignment 058583/0829
Patent Assignment
Reel/Frame 058583/0829

Assignment of Assignor's Interest

Recorded: 2022-01-07 Pages: 2
Assignor
Assignee
HUIGENE THERAPEUTICS CO., LTD.
ROOM 1002, BUILDING #7-1, NO. 160 BASHENG ROAD, SHANGHAI, 200131, CHINA
Covered Property (1)
Type Vi-E and Type Vi-F Crispr-Cas System and Uses Thereof
Application: 17/568,183 →
Publication: US 2022/0119808
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 5, 2022
From: YANG, HUI; XU, CHUNLONG; ZHOU, YINGSI; XIAO, QINGQUAN
To: CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
Reel/Frame 058560/0693 →
Change of Name Nov 21, 2023
From: HUIGENE THERAPEUTICS CO., LTD.
To: HUIDAGENE THERAPEUTICS CO., LTD.
Reel/Frame 065658/0280 →
Assignment of Assignor's Interest Nov 22, 2023
From: HUIDAGENE THERAPEUTICS CO., LTD.
To: HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
Reel/Frame 065646/0545 →